Change in temperature from baseline. by Katharyn L. Flickinger (4759323)

Changes of anti-oxidative enzyme and oxidative stress after in a mouse model of kidney fibrosis. by Wencheng Jin (13136262)

Spatial patterns of developmental changes in nodal entropy using different statistical models. by Tianyuan Lei (19683861)

RTA408 significantly reduces RGCs loss in glaucoma. by Hongmei Qian (538647)

Time series comparing trends at HSJ and control hospitals in the pre-intervention and intervention period. Significance test determine if trends differ between groups. by Eva Rydahl (6260771)

Subjects:

Changes in the neutrophil count. by Lu Yang (30847)

“…The leukocyte and neutrophil counts of the patients in the bone pain group were significantly higher than those of the patients in the no bone pain group, P(WBC) = 0.001, P(ANC) = 0.002.…”

Changes in the platelet count. by Lu Yang (30847)

“…The leukocyte and neutrophil counts of the patients in the bone pain group were significantly higher than those of the patients in the no bone pain group, P(WBC) = 0.001, P(ANC) = 0.002.…”

Land use change from 1990 to 2020. by Mingyue Sun (4638535)

Changes in the number of cultural heritages over time. by Jie Li (15030)

Replication of the main behavioral patterns of actions and judgments in Experiment 3. by Claire Lugrin (21156528)

Change in drinking behaviour over time: number of visits. by M. Jordana Rivero (14610947)

Average of % peptides counts for different classes of proteins at different germination time points and significant p-value indicated as compared to soaked sample (*p< 0.05, **p<0.... by Indrani Bera (804948)

Image 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Image 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Anxiolytic (N05B) prescribing changes from 2014 to 2022. by Dainty Ei (22265317)

Antidepressant (N06A) prescribing changes from 2014 to 2022. by Dainty Ei (22265317)

Changes in the respiration rates of seeds stored under different conditions. by Junming Zhang (5446787)

Changes in inflammatory cytokine levels compared with baseline values in all patients over time. by Jia Song (495396)

Distribution of different ingredients at the same IDDSI level (Percentage and frequency) and statistical significance analysis (Chi-square test)^b'*'. by Muxi Chen (9294270)

Subjects:

Changes in sRAGE levels in BALF after 120 consecutive days of CS exposure. by Yue He (385239)

Subjects: